Short interest in PharmaCyte Biotech Inc (NASDAQ:PMCB) decreased during the last reporting period, falling from 61.68K to 51.87K. This put 1.17% of the company's publicly available shares short.

Short interest for PharmaCyte Biotech gives investors a sense of the degree to which investors are betting on the decline of PharmaCyte Biotech's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 13.60K shares traded per day, it would take 3.81 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.